Heard at SantExpo: Europe is entering a new phase in Real World Evidence (RWE), with France emerging as one of the most dynamic ecosystems in this transformation. Over recent months, momentum has significantly accelerated around sovereign and federated health data collaboration, with a clear ambition: enabling large-scale, high-quality RWE generation while maintaining strict standards of privacy, governance, and institutional data control. A key milestone in this evolution is our strategic partnership with SOFTWAY MEDICAL, aimed at developing a national federated health data network across France. This model marks an important shift for pharmaceutical companies, biotech players, CROs, and research institutions across Europe. The long-standing tension between data access and regulatory compliance is being structurally addressed. Rather than centralizing sensitive health data, this approach enables analysis directly within healthcare institutions, supporting: ✔ multicentric feasibility studies ✔ rapid and privacy-preserving cohort identification ✔ near real-time generation of Real World Evidence ✔ full alignment with institutional governance frameworks This momentum is already becoming operational. Early pilot groups in France, including Groupement des Hôpitaux de l'Institut Catholique de Lille and Groupe AHNAC, are joining the initiative, representing approximately 30 healthcare facilities and nearly 3 million patients. At scale, the ecosystem built around Softway Medical includes: - 1,400 hospitals and clinics - 1,000 imaging centers - 400 laboratories - and hundreds of additional outpatient care structures This creates a significant foundation for federated, high-quality RWE generation across France. Importantly, this infrastructure is being developed in alignment with broader European objectives under the European Health Data Space (EHDS): interoperable, privacy-by-design, sovereign, and scalable. For life sciences organizations focused on accelerating feasibility studies, post-market surveillance, patient pathway analysis, or collaborative research, France is becoming a strategic hub to closely monitor. And this is only the beginning. #data #innovation #healthcare #healthtech
-
-
-
-
-
+2